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Abstract
Introduction: The hypoxia-inducible factor (HIF)-1 pathway can stimulate tumor cell migration and metastasis.
Furthermore, hypoxic tumors are associated with a poor prognosis. Besides the HIF-1 pathway, the unfolded
protein response (UPR) is also induced by hypoxic conditions. The PKR-like ER kinase (PERK)/activating transcription
factor 4 (ATF4)-arm of the UPR induces expression of lysosomal-associated membrane protein 3 (LAMP3), a factor
that has been linked to metastasis and poor prognosis in solid tumors. In this study the role of UPR-induced
LAMP3 in hypoxia-mediated migration of breast cancer cells was examined.
Methods: A number of in vitro metastasis models were used to study the migration and invasion of MDA-MB-231
breast cancer cells under hypoxic conditions. PERK, ATF4 and their downstream factor LAMP3 were knocked down
to examine their role in cell migration. In addition, multicellular tumor spheroids were used to study the
involvement of the tumor microenvironment in invasion.
Results: Using transwell assays, migration of different breast cancer cell lines was assessed. A direct correlation was
found between cell migration and baseline LAMP3 expression. Furthermore, moderate hypoxia (1% O2) was found
to be optimal in stimulating migration of MDA-MB-231 cells. siRNA mediated knockdown of PERK, ATF4 and
LAMP3 reduced migration of cells under these conditions. Using gap closure assays, similar results were found. In a
three-dimensional invasion assay into collagen, LAMP3 knockdown cells showed a diminished capacity to invade
compared to control cells when collectively grown in multicellular spheroids.
Conclusions: Thus, the PERK/ATF4/LAMP3-arm of the UPR is an additional pathway mediating hypoxia-induced
breast cancer cell migration.
Introduction
Breast cancer mortality is caused foremost by the spread
of cancer cells within the host in a process called metasta-
sis [1]. Before tumor cells can metastasize, the tumor will
need to invade, seek access to the lymphatic or vascular
system and colonize the metastatic site [2,3]. Insights in
this process will aid in the prevention of cancer metastasis
and help improve prognosis.
An important characteristic of most solid tumors is the
presence of hypoxic regions [4-6]. Absent or inadequate
vasculature within the tumor causes disruption of the sup-
ply of blood and consequentially an impaired delivery of
oxygen and nutrients and an impaired removal of carbon
dioxide and waste products. Several studies found low
oxygen tension in tumors to be an adverse prognostic
marker in different tumor types [7-10]. In addition, endo-
genous hypoxia-related markers, such as carbonic anhy-
drase-IX, were also shown to negatively influence patient
outcome in breast cancer [11,12]. Furthermore, hypoxic
tumors were found to correlate with metastatic occur-
rences: patients with hypoxic primary tumors developed
more metastases than patients with less hypoxic tumors
[7,13-15]. Mechanistically, numerous factors have been
identified that are induced by hypoxia and that can
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promote metastasis (reviewed in [16-20]). The common
denominator of most, if not all, of these factors is that
they are either directly or indirectly influenced by the
action of the family of master transcription regulators dur-
ing hypoxic conditions: the hypoxia-inducible factor
(HIF)-family [18].
Recently, a separate pathway from the HIFs was
described, which is able to regulate gene expression during
hypoxia, namely the unfolded protein response or UPR
[21-24]. Within this response three distinct arms have
been classified: the PKR-like endoplasmic reticulum kinase
(PERK)/activating transcription factor 4 (ATF4)-arm, the
inositol-requiring protein 1 (IRE1)-arm and the activating
transcription factor 6 (ATF6)-arm. These pathways are
activated during endoplasmic reticulum stress conditions
and enable cell survival by regulating apoptosis, angiogen-
esis and autophagy [22-25]. Thus far, the UPR has not
been directly implicated in hypoxia-induced metastasis.
However, recently lysosomal-associated membrane protein
3 (LAMP3, also known as DC-LAMP, TSC-403 or CD208)
was identified as a factor induced by hypoxia as part of the
PERK/ATF4 arm of the UPR [26,27]. In addition, we
found that LAMP3 has prognostic relevance in breast can-
cer [28]. Two homologs of LAMP3, LAMP1 and LAMP2,
have been associated with cancer metastasis previously
[29,30]. LAMP3 itself was also found to be involved in
metastasis: overexpression of LAMP3 in a cervical xeno-
graft model showed an increased metastatic potential [31].
In what way LAMP3 is involved in breast cancer metasta-
sis and which role hypoxia may have in this process is
unknown. Therefore, we set out to determine whether the
UPR can influence migration and invasion of breast cancer
cells via LAMP3 under hypoxic conditions.
Materials and methods
Cell culture and hypoxic incubations
All cell lines used were obtained from LGC Promochem
(Teddington, UK) and maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% (vol/vol)
fetal bovine serum (FBS), 20 mM Hepes, 1 × nonessential
amino acid, 2 mM L-glutamine and 10 U/ml penicillin,
10 μg/ml streptomycin (all from PAA Laboratories, Cölbe,
Germany) at 37°C with 5% CO2. Hypoxic conditions were
induced with a H35 Hypoxystation (Don Whitley Scientific
Ltd, Shipley, UK).
Cell migration using modified Boyden Chambers
Membranes with 8 μm pores (Greiner Bio-one, Alphen a/
d Rijn, The Netherlands) were used in a 24-wells format.
A total of 40,000 cells, serum-starved overnight where
indicated, were added to the upper compartment. The
lower compartment was filled with standard cell culture
medium. Cells were allowed to migrate for 24 hours,
after which chambers were fixed for 10 minutes in cold
70% ethanol. Membranes were stained with 0.5% (w/v)
crystal violet (Sigma-Aldrich, St. Louis, MO, USA) for
30 minutes and subsequently washed thoroughly with tap
water. Cells that had not migrated to the lower compart-
ment were removed with a cotton swab. Migrated cells
were quantified by solubilizing bound crystal violet in 1%
(wt/vol) sodium dodecyl sulfate (SDS, Sigma-Aldrich) for
1 hour at 37°C. Absorbance was measured at 595 nm.
RNA isolation, cDNA synthesis and quantitative
polymerase chain reactions (qPCR)
RNA was isolated with Norgen’s total RNA purification
kit (Norgen Biotek Corp., Thorold, Canada) and stored at
-80°C until further processing. cDNA was synthesized
using the iScript cDNA synthesis kit (Bio-Rad Labora-
tories Inc., Richmond, CA, USA) with 1 μg RNA as
input. The following primers were used for the qPCR:
PERK FW: 5’-CTGATTTTGAGCCAATTC-3’ and RV:
5’- CCGGTACTCGCGTCGCTG-3’, ATF4 FW: 5’-CCTT
CACCTTCTTACAACCT-3’ and RV: 5’-GTAGTC
TGGCTTCCTATCTC-3’, LAMP3 FW: 5’-TGAAA
ACAACCGATGTCCAA-3’ and RV: 5’-TCAGACGA
GCACTCATCCAC-3’.
qPCR was carried out on a CFX96 real-time PCR
detection system (Bio-Rad) with SYBR Green (Applied
Biosystems, Foster City, CA, USA). As a reference gene,
hypoxanthine-guanine phosphoribosyltransferase (HPRT)
in a pre-developed assay (Applied Biosystems) was used.
Transient transfection
Cells were transfected transiently for PERK, ATF4 or
LAMP3 using mission siRNAs (Sigma-Aldrich):
PERK (NM_004836), SASI_Hs01_00096845 and
SASI_Hs01_00096846
ATF4 (NM_001675), SASI_Hs02_00332313 and
SASI_Hs01_00175197
LAMP3 (NM_014398), SASI_Hs01_00214233 and
SASI_Hs02_00345584
Transfections were performed using Saint-Red (Synvo-
lux Therapeutics, Groningen, The Netherlands) accord-
ing to the manufacturer’s instructions.
Generation of stable MDA-MB-231 shLamp3 pools
A U6 promoter-driven short hairpin RNA (shRNA) expres-
sion vector targeting LAMP3 and a non-targeting control
vector (PLKO1_shLAMP3 (TRCN0000148784, number
842) and PLKO.1 control, respectively) were purchased
from Sigma-Aldrich. Briefly, pseudotyped lentiviral particles
were produced in HEK293FT cells using the ViraPower
lentiviral expression system according to the manufacturer’s
instructions (Invitrogen, Carlsbad, CA, USA). MDA-MB-
231 cells were infected at a low passage number after
which a pool of transfected cells was derived by puromycin
(4 μg/ml) selection for approximately 10 days.
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Colony-forming assays
For the colony-forming assays 500 transiently transfected
cells were plated in T25 cell culture flasks (Greiner Bio-
one) and allowed to adhere overnight. Cells were incu-
bated under hypoxic conditions (1% O2) for 24 hours after
which they were transferred to the normoxic incubator
and given time to form colonies. Once colonies in the nor-
moxic controls comprised of at least 50 cells, flasks were
fixated in 70% ethanol for 10 minutes at 4°C and stained
with 0.5% crystal violet for 30 minutes. Colonies of at least
50 cells were scored manually.
Gap closure assays
Monolayer gap closure assays (formerly known as scratch
assays) were conducted using silicone cell culture inserts
(Ibidi, Martinsried, Germany) attached to culture plates.
In short, 30,000 cells were seeded in the inserts and
allowed to recover overnight to form a confluent mono-
layer. Inserts were removed with tweezers, after which
cells were rinsed thrice with Hank’s buffered saline solu-
tion (HBSS, PAA Laboratories) to remove detached cells.
Culture medium was re-added and closure of the gap
was followed for 24 hours using live imaging (see below).
Gap closure was quantified using ImageJ (National Insti-
tutes of Health, Bethesda, MD, USA).
Spheroid culture
Multicellular tumor spheroids were prepared from con-
ventional monolayer cultures using an adapted liquid
overlay technique. In short, V-shaped 96-wells plates
(Greiner Bio-one) were coated with 0.5% (wt/vol) poly-
HEMA (Sigma-Aldrich). A total of 1,000 cells in 100 μl
of standard culture medium with 2.5% (vol/vol) Matrigel
(BD Biosciences, San Jose, CA, USA) were added to each
well, after which cells were spun down for 10 minutes at
1,000 × g. Within 24 hours spheroids were formed.
Pimonidazole staining
After formation, MDA-MB-231 spheroids were incubated
for 1 hour with 200 μM of pimonidazole (1-[(2-hydroxy-3-
piperidinyl)propyl]-2-nitroimidazole hydrochloride,
Natural Pharmacia International Inc., Burlington, MA,
USA). Next, spheroids were fixed in 4% paraformaldehyde
(Merck Chemicals, Darmstadt, Germany), and embedded
in paraffin. Staining was performed on 5-μm sections as
previously described [28], using the following antibodies:
mouse-anti-pimonidazole (Natural Pharmacia Interna-
tional Inc.) diluted 1:800 and biotin-conjugated donkey
anti-mouse IgG (715-066-150, Jackson ImmunoResearch
Laboratories Inc., West Grove, PA, USA) diluted 1:200.
Cell labeling with cell tracker
To label cells with CellTracker Green (Life Technolo-
gies, Carlsbad, CA, USA) or CellTracker Orange (Life
Technologies), 0.15 × 106 cells/ml were seeded in a T75
cell culture flask (Greiner Bio-one). Cells were allowed
to adhere, after which CellTracker was dissolved in
DMSO and added at 10 μM to the cell culture medium.
Flasks were incubated at 37°C for 45 minutes. Next, cell
culture medium was replenished and cells were allowed
to recover for 30 minutes, after which they were ready
for further experimentation.
Spheroid invasion assays in collagen
Twenty-four hours after formation, spheroids were
embedded into collagen. Spheroids were collected in a
15 ml tube and allowed to descend to the bottom. Cell
culture medium was renewed once. Next, the spheroids
were combined with 4 mg/ml of rat-tail collagen type I
(BD Biosciences), according to the manufacturer’s
instructions. The collagen was allowed to polymerize for
10 minutes at room temperature, after which the mixture
was pipetted carefully into a 12-wells plate (Greiner Bio-
one). The collagen disk was incubated at 37°C until fully
solidified, after which standard cell culture medium was
added. Spheroids were allowed to invade the collagen for
several days, as indicated in the legends to the figures.
F-actin staining
After invasion of spheroids into collagen, collagen disks
were fixed in 4% paraformaldehyde for 30 minutes at
room temperature. Next, disks were washed with PBS,
after which they were incubated with Alexa 488-conju-
gated Phalloidin (1:100; Life Technologies) for 3 hours at
room temperature. After washing once more with PBS,
images were acquired.
Live imaging and microscopy
Live imaging of cells was performed using the JULI (Just
Unbelievable Live Imaging) system from PAA. All other
microscopic images were obtained using a Leica DM
6000 fluorescence microscope in combination with IPLab
imaging software (Scanalytics Inc., Fairfax, VA, USA).
Data analysis and statistics
Unless stated otherwise, all data are presented as mean
values ± standard deviation. Statistical analysis was carried
out using Student’s t tests or one-way analysis of variance
(ANOVA) with Tukey’s post hoc test where appropriate
unless stated otherwise. Two-sided P values < 0.05 were
considered statistically significant. Asterisks indicate statis-
tical significance: *** is P < 0.001, ** is P < 0.01 and * is
P < 0.05.
Results
Breast cancer cell migration in transwell assays
To study the role of the UPR in the process of breast can-
cer cell migration, a number of models for in vitro
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metastasis were used. First, cell migration was studied in
a series of six breast cancer cell lines under normoxic
conditions using a transwell assay. In this assay cells have
to actively migrate through a porous membrane. Cells
were serum-deprived overnight and added to the upper
compartment of modified Boyden chambers. In the lower
compartment serum was added as a chemoattractant. As
shown in Figure 1A, vast differences were found in the
capability of cells to migrate to the lower compartment.
The largest percentage of migrated cells was found in
MDA-MB-231 and MDA-MB-468 cells, both triple-nega-
tive cell lines (that is, lacking expression of the estrogen
receptor, progesterone receptor and human epidermal
growth factor receptor 2). In contrast, MCF-7 and MDA-
MB-175 cells demonstrated very little migration. A direct
comparison between the potential to migrate and the
expression of LAMP3 on the mRNA level revealed a
moderate correlation in this small group of cell lines (see
Figure 1B). All subsequent experiments were performed
with the MDA-MB-231 cells, a commonly used breast
cancer cell line to study cell migration.
Importance of serum deprivation on migration of MDA-
MB-231 cells in a transwell assay
The standard protocol for a transwell assay includes
serum deprivation of the cells before the assay. This
enables the addition of serum as a chemoattractant to
the lower compartment. However, starvation induces the
UPR profoundly and could therefore influence cell migra-
tion, especially under hypoxic conditions. In the present
study, the chemoattractant function of serum was con-
firmed: overnight starvation of cells led to an increase in
migration compared to cells that were not starved and
thus allowed to migrate in complete medium (see Figure
2A). Next, this assay was used to establish the optimal
percentage of oxygen to increase the migration of MDA-
MB-231 breast cancer cells, in both serum-depleted and
serum-supplemented conditions. When cells were
serum-deprived overnight, cells migrated optimally at 1%
O2 (see Figure 2B). Cell migration decreased at lower or
higher oxygen concentrations. Subsequently, the assay
was performed without starvation. The availability of
serum influenced the optimal oxygen percentage pro-
foundly. Figure 2C shows that in the presence of serum
cells favored lower oxygen percentages for optimal cell
migration (0.1% O2).
Effect of knockdown of PERK, ATF4 and LAMP3 on cell
migration in transwell assay during hypoxia
Next, the effect of knockdown of PERK, ATF4 and
LAMP3 on cell migration during hypoxia using the trans-
well assay was studied. First, we examined whether PERK,
ATF4 and LAMP3 expression was induced by 1% O2 (see
Figure 3A). Expression of these UPR components showed
a moderate induction. Next, to ensure that any effects of
knockdown on the migratory capacity during hypoxia
were not due to reduced survival of the cells, a series of
colony-forming assays was performed first. No significant
effect of hypoxia (1% O2) on colony-forming ability of
knockdown cells was found in the timeframe in which
assays are performed (see Figure 3B). Figure 3C shows
that transfection with the siRNAs used successfully
diminished expression of the mRNA of PERK, ATF4 and
LAMP3. In addition, knockdown of PERK and ATF4
reduced the expression of their downstream targets (that
is ATF4 and LAMP3) after serum starvation (see Figure
3D). Subsequently, transwell assays were performed.
First, cell migration through the porous membrane was
studied at 1% O2 under serum-starved conditions. The
most profound effect of knockdown on cell migration
was induced when cells were preincubated under hypoxic
conditions prior to the assay, which itself was also per-
formed under hypoxia (see Figure 3E). Hypoxia without
preincubation showed a diminished migration of cells for
all knockdowns tested, but the effect was less profound
than with the preincubated cells. Performing the assay in
normoxic conditions led to a non-significant decrease in
cell migration and only for some of the knockdowns
tested. In addition, the cell migration after knockdown in
a transwell assay at 0.1% O2, without serum starvation
was also studied (see Figure 3F). Here, effects similar to
the assay at 1% O2 were found, albeit less prominent.
Migration of MDA-MB-231 breast cancer cells in a gap
closure assay under hypoxic conditions
To confirm and extend the data from the transwell assay,
similar experiments were performed using a gap closure
assay, which does not require serum deprivation. First, the
effect of exposure to hypoxia on the migration of MDA-
MB-231 breast cancer cells was studied. Figure 4 shows the
percentage of the gap that the cells filled in a 16-hour per-
iod. Compared to normoxic conditions, 1% O2 showed the
largest percentage of gap closure. 0.5% O2 revealed a mod-
erate but still significant effect. Exposure to even lower
oxygen concentrations, that is 0.1% O2, did not reveal an
increase in gap closure speed compared to normoxia.
Effect of knockdown of PERK, ATF4 and LAMP3 on cell
migration during hypoxia in a gap closure assay
As 1% O2 was found to be the optimal level of hypoxia
for cells to migrate, subsequent gap closure experiments
were performed at this oxygen level. Figure 5 shows the
effect of knockdown of PERK, ATF4 and LAMP3 on
migration of MDA-MB-231 cells. Under normoxic condi-
tions no significant difference between cells transfected
with a negative control and cells transfected with siRNA
against PERK, ATF4 or LAMP3 could be demonstrated
(see Figure 5A, C and 5E). In contrast, when the assay
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was performed under 1% O2 a considerable effect was
observed (see Figure 5B, D and 5F). Knockdown of
PERK, ATF4 or LAMP3 led to a substantial decrease in
the speed at which cells close the created gap (see also
Additional file 1).
Importance of the tumor microenvironment for migration
of MDA-MB-231 cells
All assays used so far required an artificial induction of
hypoxic conditions. To study the effect of hypoxia on
migration with endogenous hypoxia, multicellular tumor
Figure 1 Migration of breast cancer cells correlates with LAMP3 mRNA expression. (A) Migration of six different breast cancer cell lines
under normoxic conditions during 24 hours in a transwell assay. (B) mRNA expression of LAMP3 in the same six cell lines. Results are from two
representative experiments with three replicates each. LAMP3, lysosomal-associated membrane protein 3.
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spheroids were employed. Beyond a certain diameter,
tumor spheroids will develop a core consisting of hypoxic
cells (see Figure 6A). Expression of PERK, ATF4 and
LAMP3 was found to be higher in cells grown as a mono-
layer than cells grown in a spheroid (see Figure 6B). To
directly compare the potential to migrate of a standard
two-dimensional monolayer and three-dimensional spher-
oids both transwell and gap closure assays were per-
formed. Directly before the start of the assays, spheroids
were disintegrated by standard trypsinization into a single
cell suspension, which was used as the input for the assays.
In both assays the cells initially cultured as spheroids
showed an increased capacity to migrate compared to the
cells grown as a monolayer (see Figure 6C and 6D). Thus,
once cells have experienced a simplified, transient tumor
microenvironment, their migratory capacity increases.
Effect of LAMP3 knockdown on collagen invasion of
MDA-MB-231 spheroids
Next, the ability of spheroids generated from cells with a
stable knockdown of LAMP3 to invade a collagen matrix
was studied. Figure 7A shows that stable knockdown of
Figure 2 Serum starvation and hypoxia increase cell migration in transwell assays. (A) Effect of the addition of serum on the migration of
MDA-MB-231 cells in a transwell assay during 24 hours. Effect of exposure to hypoxia on migration of MDA-MB-231 cells in a transwell assay
under (B) serum-depleted or (C) serum-supplemented conditions, where cells were seeded in the transwell assays and then put in the hypoxic
chamber for 24 hours (black bars) or cells received a 24 hour preincubation under the hypoxic conditions indicated on the x-axis and seeded in
the transwell assays under hypoxia (white bars). Results are from two representative experiments with three replicates each. Asterisks indicate
statistical significance of knockdown compared to the corresponding negative control.
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LAMP3 attenuated the mRNA expression of LAMP3.
After 4 days of growth, both control and knockdown
spheroids were of similar size, indicating that there is no
difference in proliferation between these cells when
grown as a spheroid (see Figure 7B). MDA-MB-231 nega-
tive control spheroids were found to invade the collagen
with string-like protrusions (see Additional file 2). Stable
knockdown of LAMP3 reduced these invasive filaments
to some extent (see Figure 7C and Additional file 2). The
effect of LAMP3 knockdown on invasion of the spheroids
into collagen was quantified by measuring the surface of
collagen invaded by the spheroids. The surface of the
invasive zone was found to be smaller in the knockdown
spheroids (see Figure 7D).
The diminished invasion of LAMP3 knockdown spher-
oids was validated further by generating spheroids of a
mixed origin. Control cells were labeled with CellTracker
Green and LAMP3 knockdown cells were labeled with
CellTracker Orange. Subsequently, mixed spheroids in a
1:1 ratio were generated. Invasion of these spheroids in
collagen demonstrated the enhanced ability of the control
cells to deeply invade the collagen compared to the
LAMP3 knockdown cells (see Figure 7E). This effect was
quantified by analyzing the green and red signal present
within the spheroid body and the invasive zone (see Figure
7F). The invasive zone was divided into four circular zones
with increasing distance from the spheroid body. Analysis
of the signal present within each zone revealed that the
green signal was more prevalent in the invasive zones than
the red signal, indicating that the control cells invaded the
collagen deeper than the LAMP3 knockdown cells.
Discussion
In this study, evidence is provided that UPR-induced
LAMP3 can influence hypoxia-mediated cell migration
of breast cancer cells. We provide evidence that apart
from the established involvement of the HIF-pathway in
the induction of cancer cell spread, the UPR is a second
manner in which hypoxia is implicated in breast cancer
cell migration.
Figure 3 Knockdown of PERK, ATF4 and LAMP3 reduces cell migration under hypoxic conditions in transwell assays. (A) mRNA
expression of PERK, ATF4 and LAMP3 after exposure of MDA-MB-231 cells to 1% O2 for the time indicated on the x-axis. (B) Clonogenic survival
of MDA-MB-231 cells transiently transfected with siRNAs directed against PERK, ATF4 or LAMP3 after exposure to 1% O2 for a 24-hour period.
(C) mRNA expression of PERK, ATF4 and LAMP3 in MDA-MB-231 cells after transient transfection with siRNAs directed against the corresponding
genes. (D) mRNA expression of ATF4 and LAMP3 in MDA-MB-231 cells, transfected with siRNAs directed against PERK and ATF4, after serum
starvation for 24 hours. (E) Effect of hypoxia (1% O2) in combination with transient knockdown of PERK, ATF4 or LAMP3 in MDA-MB-231 cells on
cell migration in a transwell assay under serum-starved conditions. (F) Effect of hypoxia (0.1% O2) in combination with transient knockdown of
PERK, ATF4 or LAMP3 in MDA-MB-231 cells on cell migration in a transwell assay under serum-supplemented conditions. Preincubated cells were
exposed to hypoxic conditions 16 hours prior to the start of the assay. Assays were carried out under normoxic or hypoxic conditions during
24 hours. The preincubated assays were also performed under hypoxia. Results are from two representative experiments with three replicates
each. Asterisks indicate statistical significance of knockdown compared to the corresponding negative control. ATF4, activating transcription
factor 4; LAMP3, lysosomal-associated membrane protein 3; PERK, PKR-like endoplasmic reticulum kinase; siRNA, small interfering RNA.
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A characteristic of the UPR is its maximum induction
under conditions of severe hypoxia (< 0.2% O2) or anoxia
[32]. Indeed, LAMP3 as a UPR-induced factor was found
to have its peak of induction under these conditions
[26,28]. However, cell migration and invasion is often stu-
died under conditions of more moderate hypoxia, around
1% oxygen [33-38], conditions which maximally induce
HIF-1a expression [23]. The current study shows that
knockdown of PERK, ATF4 or LAMP3 in combination
with hypoxic exposure to 1% O2 led to a reduction in cell
migration. If the UPR and its associated factors are maxi-
mally induced by anoxia, why are the largest effects
observed at moderate levels of hypoxia? Several studies
have shown that the UPR can indeed be induced by mod-
erate hypoxia as well, but with different kinetics [21,39,40].
In this study assays were performed at 1% O2 as stronger
hypoxic conditions did not lead to a stimulation of cell
migration. Possibly, at severe hypoxic conditions, cells
apply the UPR more for cell survival [25] than migration.
In the transwell assays an intriguing effect of the addi-
tion of serum on the induction of cell migration by
hypoxia was observed. Serum-starved cells migrated most
profoundly at 1% O2, whereas serum-supplemented cells
migrated best at 0.1% O2. Serum dependency of cancer
cell invasion has been observed before [41,42]. When
MDA-MB-231 cells were serum depleted, no increase in
invasion was found for a hypoxic incubation (1.5% O2)
[42]. As addition of serum led to an increased invasion
under hypoxia, it was suggested that serum might contain
factors that increase invasion under hypoxic conditions
Figure 4 Hypoxia has a profound effect on cell migration in a gap closure assay. Shown is the percentage of the gap that is closed after
16 hours. Results are from two representative experiments with two replicates each. Asterisks indicate statistical significance compared to the
normoxic control.
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[42]. In a different study, the effect of hepatocyte growth
factor (HGF) on tumor invasion was examined in U2-OS
and SiHa cells [43]. Mild hypoxia (3% O2) was found to
increase invasion by amplifying HGF signaling, thereby
sensitizing cells to HGF stimulation [43]. These and the
current data indicate that the role of serum in cancer cell
migration and invasion is more than just a chemoattrac-
tant and that growth factor signaling has a vast influence
on the effects of hypoxia in migration and invasion assays.
Trying to survive during hypoxia is of critical importance
for cells. Depriving cells of serum may make survival even
more difficult. Possibly, without serum and under severe
hypoxic conditions (0.1% O2) cells are not migrating as
fast as under moderate hypoxia (1% O2) because cell survi-
val is more essential. When serum is present, the need for
survival may become less critical even at 0.1% O2, causing
the increase in cell migration.
The importance of the tumor microenvironment dur-
ing cell migration was emphasized when migration assays
were performed with cells grown as monolayer and cells
initially grown as spheroids. The latter were found to be
more migratory than the former. In other words, cells
that experienced a simplified microenvironment prior to
the assay were more migratory, despite the fact that
Figure 5 Knockdown of PERK, ATF4 and LAMP3 reduces cell migration under hypoxic conditions in gap closure assays. (A-F) Effect of
hypoxia (1% O2) in combination with transient knockdown of PERK, ATF4 or LAMP3 in MDA-MB-231 cells on cell migration in a gap closure
assay. Results are from two representative experiments. ATF4, activating transcription factor 4; LAMP3, lysosomal-associated membrane protein 3;
PERK, PKR-like endoplasmic reticulum kinase.
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spheroids had to be disintegrated back to a single-cell
suspension. This behavior was also observed previously
with murine breast cancer cell lines in transwell invasion
assays [44]. As the spheroids used contain a central
hypoxic core, the enhanced ability of spheroid cells to
migrate or invade could be a consequence of hypoxia.
This, however, remains to be established.
With the evidence that LAMP3 is involved in hypoxia-
induced cell migration, it needs to be elucidated which
mechanism LAMP3 uses to cause the actual spread of
cancer cells. LAMP3 protein under physiological condi-
tions is localized within the lysosomal membrane [45]. For
LAMP1 and LAMP2 it has been previously established
that their expression can relocalize to the plasma mem-
brane in cancer cells [29]. Cell lines with a stronger meta-
static capacity showed an enhanced expression of LAMP1
and LAMP2 on the cell membrane [29]. It is believed that
LAMP surface expression provides a cancer cell with
means to attach to selectins on endothelial cells and
enhance their capacity to form metastases [30]. A similar
mechanism could be responsible for the role of LAMP3 in
hypoxia-induced cell migration. LAMP3 was found to
have the ability to relocalize to the plasma membrane
upon influenza A virus infections in HeLa cells [46].
Nevertheless, we have not been able to show LAMP3
expression on the cell surface in the MDA-MB-231 cells
used, under either normoxic or hypoxic conditions.
Immunohistochemically, in MDA-MB-231 cells we have
only observed LAMP3 expression in the cytoplasm. An
alternative explanation for the function of LAMP3 in cell
migration is the link LAMP proteins have with autophagy
[47]. Autophagy has been previously suggested as a possi-
ble mechanism responsible for increased survival and
increased metastasis of cancer cells [48,49]. Analysis of the
autophagy marker LC3B expression in a large subset of
breast tumors revealed that it is associated with metastasis
and a worse outcome [50]. However, Indelicato et al.
found that chemically induced autophagy results in
Figure 6 Cells derived from tumor spheroids are more migratory than monolayer cells. (A) MDA-MB-231 spheroid stained against the
hypoxia marker pimonidazole. Bar is 100 μm, original magnification is 200 x. (B) mRNA expression of PERK, ATF4 and LAMP3 in MDA-MB-231
monolayers compared to cells grown as spheroids. Migration of monolayer cells compared to cell initially grown as a spheroid in a transwell
assay (C) during 24 hours and a gap closure assay (D) during 16 hours in standard cell culture medium. Spheroids were disintegrated into a
single-cell suspension prior to the start of the assay. Results are from two representative experiments with three replicates each. ATF4, activating
transcription factor 4; LAMP3, lysosomal-associated membrane protein 3; PERK, PKR-like endoplasmic reticulum kinase.
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Figure 7 Knockdown of LAMP3 reduces invasion of spheroids into collagen. (A) Expression of LAMP3 mRNA in control cells versus LAMP3
knockdown cells. (B) Spheroid size of MDA-MB-231 control and LAMP3 knockdown spheroids after 4 days of growth. Results are from two
independent experiments with 32 replicates each. (C) F-actin staining of MDA-MB-231 spheroids of control and LAMP3 knockdown cells, after 6
days of invasion in collagen. Bar is 100 μm, original magnification is 50 x. (D) Surface of collagen invaded by MDA-MB-231 control and LAMP3
knockdown spheroids during 72 hours. (E) Collagen invasion of a mixed MDA-MB-231 spheroid after 6 days. Control cells were labeled with
CellTracker Green and LAMP3 knockdown cells were labeled with CellTracker Orange. Control and LAMP3 knockdown cells were mixed in a 1:1
ratio. Bar is 100 μm, original magnification is 100 x. (F) Quantification of E. The total amount of green and red signal was analyzed in five
different zones: the spheroid body and four consecutive invasive zones, n = 5. LAMP3, lysosomal-associated membrane protein 3.
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reduced invasion of MDA-MB-231 cells under both nor-
moxic and hypoxic (1% O2) conditions, whereas LC3B
silenced cells showed a decreased invasion during hypoxic
conditions [37]. Thus, there is evidence that autophagy
may function as a mechanism behind hypoxia-induced
metastasis, but its precise role is far from clarified.
Conclusions
In conclusion, this study provides evidence that the UPR
with LAMP3 is involved in the process of hypoxia-
induced cell migration. In addition, growth factor signal-
ing via the serum component of cell culture medium is a
factor of vital importance in the migration of cells under
conditions of both moderate and severe hypoxia. Further-
more, the tumor microenvironment, experienced by cells
when grown as multicellular spheroids is of significance
in the process of cell migration and invasion. The PERK/
ATF4/LAMP3 arm of the UPR might function as a new
target for therapy combating hypoxia-induced metastasis
in breast cancer.
Additional material
Additional file 1: Effect of hypoxia (1% O2) in combination with
transient knockdown of PERK, ATF4 or LAMP3 in MDA-MB-231 cells
on cell migration in a gap closure assay. Shown are time-lapse
movies with 7 frames per second. Images were acquired during 24 hours
at a 5-minute interval. Original magnification is 100 x.
Additional file 2: Invasion of MDA-MB-231 control and LAMP3
knockdown spheroids into a collagen matrix. Shown are time-lapse
movies with 7 frames per second. Images were acquired during 72 hours
at a 15-minute interval. Original magnification is 200 x.
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